Search research articles
Contact Us
Filters
Showing results (11-20 of 352) with videos related to
Page
of 36
Sort By:
Immunology Today
|
October 8, 2014
The two-chain structure of high-affinity IL-2 receptors
K A Smith
Annual Review of Cell Biology
|
January 1, 1989
The interleukin 2 receptor
K A Smith
Contemporary Topics in Immunobiology
|
January 1, 1980
Continuous cytotoxic T-cell lines
K A Smith
The Canadian Nurse
|
January 1, 1981
Caring for foster children in the community
K A Smith
Journal of the Royal Army Medical Corps
|
February 1, 1992
Documentation of blood for transfusion
K A Smith
The Cancer Journal From Scientific American
|
February 11, 1998
Rational interleukin-2 therapy
K A Smith
Advances in Experimental Medicine and Biology
|
January 1, 1987
Dissection of the molecular events occurring during T cell cycle progression
K A Smith
AIDS (London, England)
|
June 27, 2001
Low-dose daily interleukin-2 immunotherapy: accelerating immune restoration and expanding HIV-specific T-cell immunity without toxicity
K A Smith
Social Science & Medicine
|
March 1, 1975
Health priorities in the poorer countries
K A Smith
Blood
|
March 15, 1993
Lowest dose interleukin-2 immunotherapy
K A Smith
Page
of 36
Search research articles
Search
Showing results (11-20 of 352) with videos related to
Sort By:
Page
of 36
Immunology Today
|
October 8, 2014
The two-chain structure of high-affinity IL-2 receptors
K A Smith
Annual Review of Cell Biology
|
January 1, 1989
The interleukin 2 receptor
K A Smith
Contemporary Topics in Immunobiology
|
January 1, 1980
Continuous cytotoxic T-cell lines
K A Smith
The Canadian Nurse
|
January 1, 1981
Caring for foster children in the community
K A Smith
Journal of the Royal Army Medical Corps
|
February 1, 1992
Documentation of blood for transfusion
K A Smith
The Cancer Journal From Scientific American
|
February 11, 1998
Rational interleukin-2 therapy
K A Smith
Advances in Experimental Medicine and Biology
|
January 1, 1987
Dissection of the molecular events occurring during T cell cycle progression
K A Smith
AIDS (London, England)
|
June 27, 2001
Low-dose daily interleukin-2 immunotherapy: accelerating immune restoration and expanding HIV-specific T-cell immunity without toxicity
K A Smith
Social Science & Medicine
|
March 1, 1975
Health priorities in the poorer countries
K A Smith
Blood
|
March 15, 1993
Lowest dose interleukin-2 immunotherapy
K A Smith
Page
of 36